289 Progress in drugging CYP1A1, 1B1 and CYP2W1 overexpressed in cancer
Pors, K, Le Morvan, V, Travica, S, Shnyder, S.D, Sutherland, M, Sheldrake, H.M, Searcey, M, Johansson, I, Mkrtchian, S, Loadman, P.M, Robert, J, Ingelman-Sundberg, M, Patterson, L.H
Published in European journal of cancer (1990) (01.11.2014)
Published in European journal of cancer (1990) (01.11.2014)
Get full text
Journal Article
Colon Cancer―Specific Cytochrome P450 2W1 Converts Duocarmycin Analogues into Potent Tumor Cytotoxins
TRAVICA, Sandra, PORS, Klaus, LOADMAN, Paul M, SHNYDER, Steven D, JOHANSSON, Inger, ALANDAS, Mohammed N, SHELDRAKE, Helen M, MKRTCHIAN, Souren, PATTERSON, Laurence H, INGELMAN-SUNDBERG, Magnus
Published in Clinical cancer research (01.06.2013)
Published in Clinical cancer research (01.06.2013)
Get full text
Journal Article
Re-engineering of the Duocarmycin Structural Architecture Enables Bioprecursor Development Targeting CYP1A1 and CYP2W1 for Biological Activity
Sheldrake, Helen M, Travica, Sandra, Johansson, Inger, Loadman, Paul M, Sutherland, Mark, Elsalem, Lina, Illingworth, Nicola, Cresswell, Alexander J, Reuillon, Tristan, Shnyder, Steven D, Mkrtchian, Souren, Searcey, Mark, Ingelman-Sundberg, Magnus, Patterson, Laurence H, Pors, Klaus
Published in Journal of medicinal chemistry (08.08.2013)
Published in Journal of medicinal chemistry (08.08.2013)
Get full text
Journal Article
Colorectal cancer-specific cytochrome P450 2W1: intracellular localization, glycosylation, and catalytic activity
Gomez, Alvin, Nekvindova, Jana, Travica, Sandra, Lee, Mi-Young, Johansson, Inger, Edler, David, Mkrtchian, Souren, Ingelman-Sundberg, Magnus
Published in Molecular pharmacology (01.12.2010)
Published in Molecular pharmacology (01.12.2010)
Get full text
Journal Article
CYP2W1 polymorphism: functional aspects and relation to risk for colorectal cancer
Stenstedt, Kristina, Travica, Sandra, Guo, Jia, Barragan, Isabel, Pors, Klaus, Patterson, Laurence, Edler, David, Mkrtchian, Souren, Johansson, Inger, Ingelman-Sundberg, Magnus
Published in Pharmacogenomics (01.10.2013)
Published in Pharmacogenomics (01.10.2013)
Get full text
Journal Article
Progress in drugging CYP1A1, 1B1 and CYP2W1 overexpressed in cancer
Pors, K, Le Morvan, V, Travica, S, Shnyder, SD, Sutherland, M, Sheldrake, HM, Searcey, M, Johansson, I, Mkrtchian, S, Loadman, PM, Robert, J, Ingelman-Sundberg, M, Patterson, LH
Published in EUROPEAN JOURNAL OF CANCER (2014)
Published in EUROPEAN JOURNAL OF CANCER (2014)
Get full text
Conference Proceeding
CYP2W1 as a novel therapeutic target in colon cancer
Pors, K, Loadman, PM, Travica, S, Shnyder, SD, Sutherland, M, Sheldrake, H, Searcey, M, Johansson, I, Mkrtchian, S, Ingelman-Sundberg, M, Patterson, LH
Published in CANCER RESEARCH (2014)
Published in CANCER RESEARCH (2014)
Get full text
Conference Proceeding
Hormone replacement therapy with 17 beta-estradiol dydrogesterone: results of a 3-month open-label study
Grisar, J, Travica, S, Metka, M, Pietschmann, P
Published in Wiener Klinische Wochenschrift (23.12.1999)
Get more information
Published in Wiener Klinische Wochenschrift (23.12.1999)
Journal Article
Clinical profile of a new hormone replacement therapy containing 2 mg 17β-estradiol and 10 mg dydrogesterone
Sator, Michael O, Nagele, Fritz, Sator, Paul, Travica, Sanja, Gruber, Doris, Huber, Johannes C
Published in Maturitas (31.03.2000)
Published in Maturitas (31.03.2000)
Get full text
Journal Article